Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for March 2010
March 1, 2010
- Merck KGaA and Millipore Announce Transaction
- Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
- AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
- AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
- Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development
- Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development
- Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of OSI Pharmaceuticals, Inc.
- OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
- SuperGen Reports 2009 Fourth Quarter and Year-End Financial Results
March 2, 2010
- Watson Signs Agreement to Divest Equity Interest in ScinoPharm
- Baxter to Acquire All Outstanding Equity of ApaTech, Including ACTIFUSE
- Med Ad News' 21st Annual Manny Awards Will Honor Healthcare Advertising Agencies
- Abbott and Enanta Announce Advancement of Hepatitis C Collaboration
- Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman
March 3, 2010
- Nabi Shareholders Approve Deal With Glaxo
- Dendreon Rises; FDA Says No Meeting on Provenge
- FDA Grants Final Approval For Generic Flomax
- Teva Announces Favorable Court Ruling in Generic Hyzaar and Cozaar Litigation
- Lundbeck and Takeda Finalize Plans to Initiate Phase III Pivotal Clinical Trials with Lu AA21004 and Lu AA24530
- Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine
- Danish Lundbeck to Launch Two Depression Drugs in Phase III
March 4, 2010
- Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
- Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' Crinone Progesterone Gel Product Line
- KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs
- Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy in Meeting with Investment Community
- NICE Appraisal of azacitidine for Myelodysplastic Syndromes
- H. Lundbeck A/S (DK) - Fourth Quarter and Full Year Report 2009 - Lundbeck Delivers 22 Percent Revenue Growth for 2009 and Meets Financial Expectations for 2009
- District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R)
March 5, 2010
- Merck Statement on Vioxx Judgment in Australia
- Unilife and sanofi-aventis Agree to Exclusivity List for Unifill Ready-to-Fill Syringe
- Grassley Statement on GAO Report about FDA Office of Criminal Investigations
- Abbott Executives To Chair Medical Device Lobby
- Pfizer, Bristol-Myers Say Clot Drug Meets Goals
- Pfizer CEO Gets 12.5 Percent Raise From Last Year's $14.9M
- Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
- La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals
- XenoPort Restructures to Focus on Key Programs
March 8, 2010
- Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
- Roche and Biogen Idec Decide to Suspend Ocrelizumab Treatment - Rheumatoid Arthritis Development Programme on Hold
- Roche Suspends Arthritis Drug Study After Deaths
March 9, 2010
- Mylan Rebukes and Cites Flaws in Bayer-Sponsored Mylan-Nifedipine Extended Release Bioequivalence Study in Canada
- Nabi Closes License Deal With Glaxosmithkline
- Exelixis Announces Restructuring
- Cardiff University and Merck Serono Launch International Survey For Couples Trying To Conceive
- GSK CEO Andrew Witty Dedicates albendazole Facility in Nashik to WHO?s Global Programme to Eliminate LF
- Catalina Marketing Hires Johnson & Johnson Executive to Lead Health Care Services Division
March 10, 2010
- Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
- Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
- PhRMA Statement About Accessing Online Health Information
- Teva Announces the Appointment of Dr. Philip Frost As Chairman of Its Board of Directors
- Quantity vs. Quality: Long-Term Use of Bone-Building Osteoporosis Drugs
March 11, 2010
- Transgene Signs an Exclusive Option Agreement for the Development and Commercialization of its Immunotherapy Product TG4010
- Astra Boosts Generic Exposure with Torrent Deal
- Sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
- New Thyroid Medicine Works As Well As Statins, Study Shows
- ARCA Announces Going Concern Opinion per Nasdaq Rule 5250(b)(2)
- FDA letter prompts API manufacturer to choose partner
March 12, 2010
- Pfizer Ends Study on Potential Lung Cancer Drug
- Pfizer Says Sutent Fails In Breast Cancer Studies
- Pfizer Ends Study on Potential Lung Cancer Drug
- Genentech Says Avastin Trial Did Not Meet Goal
- Merck Provides Update on the IMPROVE-IT Trial
- FDA: No Clear Evidence Linking Bisphosphonates and Fractures
- Intellipharmaceutics Announces Settlement for its Generic Version of Focalin XR
- GlaxoSmithKline Makes Vaccine Executive Changes
- Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to Plavix U.S. Prescribing Information
- MiddleBrook Pharmaceuticals Reports Fourth Quarter 2009 and Full-Year Results; Announces Reduction in Force; Engages Broadpoint Gleacher to Assist in the Evaluation of Strategic Options
- FDA Announces New Boxed Warning on Plavix
March 15, 2010
- Amylin, Lilly and Alkermes Receive Complete Response Letter from FDA for exenatide Once Weekly Submission
- FDA Asks for Risk Plan Info on Diabetes Drug
- OSI Pharmaceuticals' Board of Directors Unanimously Rejects Astellas' Unsolicited Tender Offer
- Astellas Responds to OSI Pharmaceuticals' Rejection
- Cline Davis & Mann Announces Expansion of CDM World Agency to Paris, Milan and Montreal
March 16, 2010
- Allergan, Inc. Announces the Juvederm 'Switch Up' Campaign Educating Women on the Positive Impact Small Changes Have on Personal Appearance
- Lilly Signs Licensing Pact For Testosterone Aid
- Former Employee Fired For Refusing To Return To Work, Pfizer Maintains: In Civil Case, Scientist Says Dismissal Was Retaliation
- Mylan, Takeda Reach Agreement Over Diabetes Drugs
- Tekmira and Pfizer Initiate New Research Collaboration
- IMS Announces 17 Countries Now Rank as High-Growth ?Pharmerging' Markets; Forecast to Contribute Nearly Half of Industry Growth by 2013
March 18, 2010
- FDA Asks Consumers To Submit Questions As Part Of Transparency Plan
- WHO Suspends Vaccine By Sanofi-Aventis Subsidiary Because Of White Sediment Inside Vials
- Maine House Oks Prescription Drug Take-Back Plan
- Teva to Acquire Ratiopharm
- Novelos Therapeutics Discontinues Current Development Program for NOV-002 in NSCLC
- Roche Uniquely Positioned to Deliver Long-Term Growth
March 19, 2010
- Astellas Meets Antitrust Mark In OSI Attempt
- Pfizer Scientists Collaborating In New TB Initiative
- Scientists With Ties To Industry More Likely To Write Nice things about drugs
- Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
- Theravance Falls On Relovair Comments, Stock Offer
- Lilly Discloses Full List Of Drugs In Conn. Theft
- FDA Warns About Increased Risk of Muscle Injury with Zocor
March 22, 2010
- PhRMA Statement on Health Care Reform
- Drug Trials Have Excluded Gays
- Woman's Move Triggers Loss of Coverage for Cancer Treatment
- Acorda Applies To Extend Ampyra Patent Protection
- Health Care Reform Clears US Congress
- Acorda Applies to Extend Ampyra Patent Protection
- Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk
- GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
March 23, 2010
- Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
- Somaxon Share Offering To Fund Insomnia Drug Plan
- Ariad Says Court Rules For Lilly In Patent Case
- Biovail Founder Sells Off Shares
- Halozyme Hits 2-Year High Following Upgrade
- ARIAD Announces Court Ruling Regarding NF-kB Patent Lawsuit with Lilly
- Med Ad News Magazine Announces Nominees for the 21st Annual Manny Awards as Well as Advertising Person of the Year
- Stopping Clinical Trials Early Often Exaggerates Treatment Effects
- AMRI Files Motion for Preliminary Injunction Prohibiting Dr. Reddy's from Distributing Generic Allegra-D® 24
- Canon Communications to Produce Medical Manufacturing Event in Singapore
March 24, 2010
- Pfizer Signs Long-Term Agreement to Supply Prevenar 13 To The World's Poorest Countries
- Genzyme Announces FDA Enforcement Action Regarding Allston Plant
- AMRI Seeks Injunction On Generic Allegra-D Sales
- Pfizer Opened Its Wallet For Lobbying In 2009
- Glaxo, Pfizer Agree To Supply Pneumonia Vaccines
March 25, 2010
- Sanofi-Aventis Gets European OK For Blood Thinner
- Teva Gets Tentative Approval On Generic Argatroban
March 26, 2010
- Biovail Acquires Ampakine Compounds for Treatment of Respiratory Depression
- Sanofi-aventis Confirms Quality and Supply of Plavix, Iscover and Clopidogrel Winthrop
- Benefits of Osteoporosis Treatments Outweigh Possible Risk of Rare Femoral Fractures
- European Medicines Agency recommends precautionary recall of batches of clopidogrel-containing medicines from Acino Pharma GmbH
- Thermo Fisher to Do More Lilly Clinical Trial Work
- Thermo Fisher Scientific and Lilly Announce Expanded Clinical Trial Materials Relationship
March 29, 2010
- Antisoma plc (UK) - ATTRACT-1 Phase III Trial of ASA404 Halted Following Interim Analysis
- inVentiv Health Announces Approach From Financial Investors Regarding Possible Transaction
- K-V Pharma Won't Resume Shipping Until 4Q Or Later
- European Agency Says Rotarix Vaccine Is Safe
- European Medicines Agency Sees No Safety Concerns With The Rotarix Oral Vaccine
- Bayer Will Update Yasmin Label in the EU
- Important Correction of Drug Information About Embeda (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use C-II
March 30, 2010
- Astellas Continues Negotiating For OSI
- Sanofi-aventis: Multaq Receives Positive Recommendation by NICE in New Appraisal Consultation Document
- Medivation Announces Reduction in Workforce
- GenVec Discontinues Phase 3 Clinical Trial of TNFerade
- Lilly USA Updates Health Education Program to Help Patients With Depression Build Network of Support
- GlaxoSmithKline Launches Free Vaccine Program
- Astellas Continues Negotiating for OSI
- Medivation Lays Off 20 Percent Of Its Staff
- Neurop, Bristol-Myers Sign Drug Development Deal
- Genzyme Creates Chief Operating Officer Position
March 31, 2010
- Genzyme Names Meeker Chief Operating Officer
- GenVec Dives After Ending Cancer Drug Trial
- Johnson & Johnson Unit Gets Bid for Breast-care Business
- GSK and Isis Pharmaceuticals Collaborate on RNA Therapeutics for Rare and Infectious Diseases
- Isis Pharma And Glaxo In $1.5B Development Deal
- Companies Creating New Kids' Medicines
- Viagra Maker Sues Rival In Norfolk Federal Court
- Genzyme Names Meeker Chief Operating Officer
- Alcon Wraps Deal For Sirion Drug Rights
- FDA Warns Salix Over Metozolv Ad
- VIVUS Announces Termination of Agreement for the Development of Testosterone MDTS
- Pharmalive?s Annual ?New Drug Review And Outlook? Special Report Analyzes Market Impact Of Recently Approved Medicines And Potential Blockbusters In Clinical Development
- Pfizer Posts Details About Interactions With U.S. Physicians, Other Healthcare Professionals and Clinical Research Partners
- Cubist Pharmaceuticals to End Development of CB-500,929
- Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
